Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.64 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.55 |
| ▸ | PTPRA | P18433 | 1/20 | 0.54 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.54 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.54 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | REN | P00797 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.42 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | FCER2 | P06734 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20816850 | 1.00 | PTPN1 (0.64) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20827881 | 0.95 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816674 | 0.94 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816796 | 0.94 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816899 | 0.93 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816662 | 0.93 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816879 | 0.93 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816664 | 0.93 | PTPN1 (0.58) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816696 | 0.90 | PTPN1 (0.56) | PTPN1PTPN2PTPRAPTPN6PTPN11 | |
| SCHEMBL20816877 | 0.90 | PTPN1 (0.56) | PTPN1PTPN2PTPRAPTPN6PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190085024-A1 | Alpha-Ketoamide Inhibitors Of Cysteine Proteases | Phelix Therapeutics (US) | 2019-03-21 | — | — | US | claimed |
| US-20190085024-A1 | Alpha-Ketoamide Inhibitors Of Cysteine Proteases | Phelix Therapeutics (US) | 2019-03-21 | — | — | US | disclosed |
| US-20190085024-A1 | Alpha-Ketoamide Inhibitors Of Cysteine Proteases | Phelix Therapeutics (US) | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190085024-A1 | Alpha-Ketoamide Inhibitors Of Cysteine Proteases | CTSS, CTSB, CTSL | PTPN1 4631/4885PTPN2 4709/4885PTPRA 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.